Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-9,122
Closed -$317K 1991
2020
Q4
$317K Buy
+9,122
New +$257K 0.01% 1129
2020
Q3
Sell
-22,620
Closed -$371K 2024
2020
Q2
$371K Sell
22,620
-12,680
-36% -$193K 0.01% 1372
2020
Q1
$320K Buy
35,300
+433
+1% +$8.72K 0.02% 655
2019
Q4
$741K Buy
34,867
+24,907
+250% +$552K 0.01% 1139
2019
Q3
$229K Buy
+9,960
New +$227K ﹤0.01% 1685
2019
Q2
Sell
-55,146
Closed -$714K 1684
2019
Q1
$714K Buy
+55,146
New +$965K 0.02% 892
2018
Q4
Sell
-45,735
Closed -$1.8M 1227
2018
Q3
$1.8M Buy
+45,735
New +$2.06M 0.03% 498
2018
Q2
Sell
-24,968
Closed -$1.49M 1579
2018
Q1
$1.49M Buy
24,968
+13,468
+117% +$898K 0.02% 750
2017
Q4
$905K Buy
11,500
+6,094
+113% +$492K 0.01% 1082
2017
Q3
$454K Buy
+5,406
New +$383K 0.01% 1578

Other funds holding ADNT

Paloma Partners's ADNT Position: Q1 2021 in Review

Paloma Partners sold out of Adient (ADNT) in Q1 2021, closing a stake of 9,122 shares — an estimated $317K sold.

Paloma Partners first reported a position in ADNT in Q3 2017 and held it in 10 quarters. The position peaked at $1.8M in Q3 2018. 300 funds tracked by Wall St. Rank hold ADNT as of Q1 2021.

  • Paloma Partners reported no remaining Adient position as of Q1 2021 after selling out during the quarter.
  • Paloma Partners sold 9,122 Adient shares in Q1 2021, an estimated $317K.
  • Paloma Partners first reported a position in Adient in Q3 2017 and held it in 10 quarters.
  • Paloma Partners's Adient position peaked at $1.8M in Q3 2018.
  • 300 funds tracked by Wall St. Rank held Adient as of Q1 2021.

Based on Paloma Partners's 13F filing for Q1 2021, filed 17 May 2021.